Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats-Reference-Cited by-同舟云学术

Ipragliflozin, an SGLT2 inhibitor, exhibits a prophylactic effect on hepatic steatosis and fibrosis induced by choline-deficient l-amino acid-defined diet in rats

Published:2015-05 Issue: Volume:754 Page:19-24
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Hayashizaki-Someya Yuka,Kurosaki Eiji,Takasu Toshiyuki,Mitori Hikaru,Yamazaki Shunji,Koide Kumi,Takakura Shoji

Publisher

Elsevier BV

Subject

Pharmacology

Reference46 articles.

1. Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model;Aihara;Hepatol. Res.,2013

2. Diazoxide enhances basal metabolic rate and fat oxidation in obese Zucker rats;Alemzadeh;Metabolism,2008

3. Diazoxide attenuates insulin secretion and hepatic lipogenesis in zucker diabetic fatty rats;Alemzadeh;Med. Sci. Monit.,2005

4. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis;Belfort;N. Engl. J. Med.,2006

5. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions;Brunt;Am. J. Gastroenterol.,1999

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 inhibitor promotes ketogenesis to improve MASH by suppressing CD8+ T cell activation;Cell Metabolism;2024-09

2. SGLT-2 inhibitors as novel treatments of multiple organ fibrosis;Heliyon;2024-04

3. Prolonged impacts of sodium glucose cotransporter-2 inhibitors on metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a retrospective analysis through magnetic resonance imaging;Endocrine Journal;2024

4. Animal studies of sodium-glucose co-transporter 2 inhibitors in nonalcoholic fatty liver disease;Annals of Gastroenterology;2024

5. Antifibrotic effects of sodium-glucose cotransporter-2 inhibitors: A comprehensive review;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01